Page 2243 - Williams Hematology ( PDFDrive )
P. 2243

2218           Part XII:  Hemostasis and Thrombosis                                                                                                               Chapter 129:  Disseminated Intravascular Coagulation           2219




                 255. Klein JD, Walker FJ: Purification of a protein C activator from the venom of the     289. O’Riordan MN, Higgins JR: Haemostasis in normal and abnormal pregnancy.  Best
                  southern copperhead snake (Agkistrodon contortrix contortrix). Biochemistry 25:4175,     Pract Res Clin Obstet Gynaecol 17:385, 2003.
                  1986.                                                 290. Levi M: Disseminated intravascular coagulation (DIC) in pregnancy and the peri-par-
                 256. Weiss HJ, Phillips LL, Hopewell WS, et al: Heparin therapy in a patient bitten by a   tum period. Thromb Res 123 Suppl 2:S63, 2009.
                  saw-scaled viper (Echis carinatus), a snake whose venom activates prothrombin. Am J     291. Giles C: Intravascular coagulation in gestational hypertension and pre-eclampsia: The
                  Med 54:653, 1973.                                      value of haematological screening tests. Clin Lab Haematol 4:351, 1982.
                 257. Schulchynska-Castel H, Dvilansky A, Keynan A: eEchis colorata bites: Clinical evalua-    292. Norwitz  ER,  Hsu  CD,  Repke  JT:  Acute  complications  of  preeclampsia.  Clin Obstet
                  tion of 42 patients. A retrospective study. Isr J Med Sci 22:880, 1986.  Gynecol 45:308, 2002.
                 258. Fainaru M, Eisenberg S, Manny N, et al: The natural course of defibrination syndrome     293. Weinstein L: Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A
                  caused by Echis colorata venom in man. Thromb Diath Haemorrh 31:420, 1974.  severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 142:159, 1982.
                 259. Hall GW: Kasabach-Merritt syndrome: Pathogenesis and management. Br J Haematol     294. Sibai BM, Ramadan MK, Usta I, et al: Maternal morbidity and mortality in 442 preg-
                  112:851, 2001.                                         nancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome).
                 260. Straub PW, Kessler S, Schreiber A, et al: Chronic intravascular coagulation in Kasa-  Am J Obstet Gynecol 169:1000, 1993.
                  bach-Merritt syndrome. Preferential accumulation of fibrinogen  I in a giant heman-    295. Aarnoudse JG, Houthoff HJ, Weits J, et al: A syndrome of liver damage and intravascu-
                                                      131
                  gioma. Arch Intern Med 129:475, 1972.                  lar coagulation in the last trimester of normotensive pregnancy. A clinical and histo-
                 261. Warrell RPJ, Kempin SJ, Benua RS, et al: Intratumoral consumption of indium-111   pathological study. Br J Obstet Gynaecol 93:145, 1986.
                  labeled  platelets  in  a  patient  with  hemangiomatosis  and  intravascular  coagulation     296. Audibert F, Friedman SA, Frangieh AY, et al: Clinical utility of strict diagnostic criteria
                  (Kasabach-Merritt syndrome). Cancer 52:2256, 1983.     for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J
                 262. Propp RP, Scharfman WB: Hemangioma-thrombocytopenia syndrome associated with   Obstet Gynecol 175:460, 1996.
                  microangiopathic hemolytic anemia. Blood 28:623, 1966.    297. Barton JR, Sibai BM: Hepatic imaging in HELLP syndrome (hemolysis, elevated liver
                 263. Hesselmann S, Micke O, Marquardt T, et al: Case report: Kasabach-Merritt syndrome:   enzymes and low platelet count. Am J Obstet Gynecol 174:1820, 1996.
                  A review of the therapeutic options and case report of successful treatment with radio-    298. Sullivan CA, Magann EF, Perry KG Jr, et al: The recurrence risk of the syndrome of
                  therapy and interferon alpha. Br J Radiol 75:180, 2002.  hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations.
                 264. Mazoyer E, Enjolras O, Laurian C, et al: Coagulation abnormalities associated with   Am J Obstet Gynecol 171:940, 1994.
                  extensive venous malformations of the limbs: Differentiation from Kasabach-Merritt     299. Lee W, Clark SL, Cotton DB, et al: Septic shock during pregnancy. Am J Obstet Gynecol
                  syndrome. Clin Lab Haematol 24:243, 2002.              159:410, 1988.
                 265. Fisher DF Jr, Yawn DH, Crawford ES: Preoperative disseminated intravascular coag-    300. Romero R, Copel JA, Hobbins JC: Intrauterine fetal demise and hemostatic failure: The
                  ulation associated with aortic aneurysms. A prospective study of 76 cases. Arch Surg   fetal death syndrome. Clin Obstet Gynecol 28:24, 1985.
                  118:1252, 1983.                                       301. Berkowitz RL, Stone JL, Eddleman KA: One hundred consecutive cases of selective
                 266. Bieger R, Vreeken J, Stibbe J, et al: Arterial aneurysm as a cause of consumption coagu-  termination of an abnormal fetus in a multifetal gestation. Obstet Gynecol 90:606, 1997.
                  lopathy. N Engl J Med 285:152, 1971.                  302. Hay JE: Liver disease in pregnancy. Hepatology 47:1067, 2008.
                 267. ten Cate JW, Timmers H, Becker AE: Coagulopathy in ruptured or dissecting aortic     303. Bacq Y, Riely CA: Acute fatty liver of pregnancy: The hepatologist’s view. Gastroenterol-
                  aneurysms. Am J Med 59:171, 1975.                      ogist 1:257, 1993.
                 268. Mulcare RJ, Royster TS, Phillips LL: Intravascular coagulation in surgical procedures     304. Usta IM, Barton JR, Amon EA, et al: Acute fatty liver of pregnancy: An experience in
                  on the abdominal aorta. Surg Gynecol Obstet 143:730, 1976.  the diagnosis and management of fourteen cases. Am J Obstet Gynecol 171:1342, 1994.
                 269. Wilcox JN, Smith KM, Schwartz SM, et al: Localization of tissue factor in the normal     305. Pereira SP, O’Donohue J, Wendon J, et al: Maternal and perinatal outcome in severe
                  vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A 86:2839, 1989.  pregnancy-related liver disease. Hepatology 26:1258, 1997.
                 270. Cummins D, Segal H, Hunt BJ, et al: Chronic disseminated intravascular coagulation     306. Rahman TM, Wendon J: Severe hepatic dysfunction in pregnancy. Q J Med 95:343,
                  after surgery for abdominal aortic aneurysm: Clinical and haemostatic response to   2002.
                  dalteparin. Br J Haematol 113:658, 2001.              307. Ibdah JA, Yang Z, Bennett MJ: Liver disease in pregnancy and fetal fatty acid oxidation
                 271. Cross KS, Bouchier-Hayes D, Leahy AL: Consumptive coagulopathy following endovas-  defects. Mol Genet Metab 71:182, 2000.
                  cular stent repair of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 19:94, 2000.    308. Castro MA, Goodwin TM, Shaw KJ, et al: Disseminated intravascular coagulation
                 272. Shimazaki T, Ishimaru S, Kawaguchi S, et al: Blood coagulation and fibrinolytic   and antithrombin III depression in acute fatty liver of pregnancy. Am J Obstet Gynecol
                  response after endovascular stent grafting of thoracic aorta. J Vasc Surg 37:1213, 2003.  174:211, 1996.
                 273. Mannucci PM, Lobina GF, Caocci L, et al: Effect on blood coagulation of massive intra-    309. Watson WJ, Seeds JW: Acute fatty liver of pregnancy. Obstet Gynecol Surv 45:585, 1990.
                  vascular haemolysis. Blood 33:207, 1969.              310. Moldenhauer JS, O’brien JM, Barton JR, et al: Acute fatty liver of pregnancy associated
                 274. Butler J, Parker D, Pillai R, et al: Systemic release of neutrophil elastase and tumour   with pancreatitis: A life-threatening complication. Am J Obstet Gynecol 190:502, 2004.
                  necrosis factor alpha following ABO incompatible blood transfusion. Br J Haematol     311. Hathaway WE, Mull MM, Pechet GS: Disseminated intravascular coagulation in the
                  79:525, 1991.                                          newborn. Pediatrics 43:233, 1969.
                 275. Hamilton KK, Hattori R, Esmon CT, et al: Complement proteins C5b-9 induce vesicu-    312. Corrigan JJ Jr: Activation of coagulation and disseminated intravascular coagulation in
                  lation of the endothelial plasma membrane and expose catalytic surface for assembly of   the newborn. Am J Pediatr Hematol Oncol 1:245, 1979.
                  the prothrombinase enzyme complex. J Biol Chem 265:3809, 1990.    313. Williams MD, Chalmers EA, Gibson BE: The investigation and management of neona-
                 276. Weiner  CP: The  obstetric patient and  disseminated  intravascular  coagulation.  Clin     tal haemostasis and thrombosis. Br J Haematol 119:295, 2002.
                  Perinatol 13:705, 1986.                               314. Buchanan GR: Coagulation disorders in the neonate. Pediatr Clin North Am 33:203,
                 277. Bonnar J: Massive obstetric haemorrhage. Best Pract Res Clin Obstet Gynaecol 14:1,   1986.
                  2000.                                                 315. Stanworth SJ, Bennett C: How to tackle bleeding and thrombosis in the newborn. Early
                 278. Letsky EA: Disseminated intravascular coagulation. Best Pract Res Clin Obstet Gynaecol   Hum Dev 84:507, 2008.
                  15:623, 2001.                                         316. Corrigan JJ Jr, Ray WL, May N: Changes in the blood coagulation system associated
                 279. DeLee JB: Acase of fatal hemorrhagic diathesis with premature detachment of the pla-  with septicemia. N Engl J Med 279:851, 1968.
                  centa. Am J Obstet Gynecol 44:785, 1901.              317. Levi M, de Jonge E, van der Poll T: New treatment strategies for disseminated intravas-
                 280. Eskes TK: Abruptio placentae. A “classic” dedicated to Elizabeth Ramsey. Eur J Obstet   cular coagulation based on current understanding of the pathophysiology. Ann Med
                  Gynecol Reprod Biol 75:63, 1997.                       36:41, 2004.
                 281. Kuczynski J, Uszynski W, Zekanowska E, et al: Tissue factor (TF) and tissue factor path-    318. Alving  BM,  Spivak  JL,  DeLoughery  TG:  Consultative  hematology:  Hemostasis  and
                  way inhibitor (TFPI) in the placenta and myometrium. Eur J Obstet Gynecol Reprod Biol   transfusion issues in surgery and critical care medicine, in The American Society of
                  105:15, 2002.                                          Hematology Education Program Book, edited by JR McArthur, GP Schechter, SL Schrier,
                 282. Pritchard JA, Brekken AL: Clinical and laboratory studies on severe abruptio placentae.   p 320. American Society of Hematology, Washington DC, 1998.
                  Am J Obstet Gynecol 97:681, 1967.                     319. de Jonge E, Levi M, Stoutenbeek CP, et al: Current drug treatment strategies for dissem-
                 283. Steiner PE, Lushbaugh CC: Maternal pulmonary embolism by amniotic fluid as a cause   inated intravascular coagulation. Drugs 55:767, 1998.
                  of obstetric shock and unexpected deaths in obstetrics. JAMA 117:1245, 1941.    320. de Jonge E, van der Poll T, Kesecioglu J, et al: Anticoagulant factor concentrates in dis-
                 284. Morgan M: Amniotic fluid embolism. Anaesthesia 34:20, 1979.  seminated intravascular coagulation: Rationale for use and clinical experience. Semin
                 285. Gilbert WM, Danielsen B: Amniotic fluid embolism: Decreased mortality in a popula-  Thromb Hemost 27:667, 2001.
                  tion-based study. Obstet Gynecol 93:973, 1999.        321. Abraham E: Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell
                 286. Uszynski M, Zekanowska E, Uszynski W, et al: Tissue factor (TF) and tissue factor path-  Mol Biol 22:401, 2000.
                  way inhibitor (TFPI) in amniotic fluid and blood plasma: Implications for the mecha-    322. Levi M, Schouten M, van der Poll T: Sepsis, coagulation, and antithrombin: Old lessons
                  nism of amniotic fluid embolism. Eur J Obstet Gynecol Reprod Biol 95:163, 2001.  and new insights. Semin Thromb Hemost 34:742, 2008.
                 287. Boer K, den Hartog I, Meijers JC, et al: Tissue factor-dependent blood coagulation is     323. Fourrier F, Chopin C, Huart JJ, et al: Double-blind, placebo-controlled trial of antith-
                  enhanced following delivery irrespective of the mode of delivery. J Thromb Haemost   rombin III concentrates in septic shock with disseminated intravascular coagulation.
                  5:2415, 2007.                                          Chest 104:882, 1993.
                 288. Gibson B, Hunter D, Neame PB, et al: Thrombocytopenia in preeclampsia and eclamp-    324. Eisele B, Lamy M, Thijs LG, et al: Antithrombin III in patients with severe sepsis. A
                  sia. Semin Thromb Hemost 8:234, 1982.                  randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on







          Kaushansky_chapter 129_p2199-2220.indd   2218                                                                 17/09/15   3:46 pm
   2238   2239   2240   2241   2242   2243   2244   2245   2246   2247   2248